Cardiff University: New Trial for Gene Therapy for Frontotemporal Dementia
May 16, 2025
May 16, 2025
CARDIFF, Wales, May 16 -- Cardiff University issued the following news:
* * *
New trial for gene therapy for frontotemporal dementia
A new clinical trial, delivered in Cardiff, will investigate the use of a one-time gene therapy to stop the disease progression in patients with frontotemporal dementia.
The ASPIRE-FTD Phase 1/2 clinical trial is recruiting patients in the UK to investigate the use of AVB-101, a gene therapy, in people with fronto . . .
* * *
New trial for gene therapy for frontotemporal dementia
A new clinical trial, delivered in Cardiff, will investigate the use of a one-time gene therapy to stop the disease progression in patients with frontotemporal dementia.
The ASPIRE-FTD Phase 1/2 clinical trial is recruiting patients in the UK to investigate the use of AVB-101, a gene therapy, in people with fronto . . .